| Literature DB >> 35035918 |
Majid Aminzare1, Roya Moniri1, Hassan Hassanzad Azar1, Mohammad Reza Mehrasbi1.
Abstract
The aim of present study was to compare the in vitro antioxidant and antibacterial properties of carboxymethyl cellulose (CMC) films containing resveratrol (RES) and eugenol (EUG), alone and in combination, and to calculate the dose interactions between them. At first, the total phenolic content of CMC films was evaluated. Then, their antioxidant and antibacterial effects of films were determined using DPPH, reducing power, disk diffusion, and broth dilution methods. Finally, concentrations of RES and EUG which showed better results in the CMC films were added in combination forms to calculate their antioxidant and antibacterial interactions. The results showed that addition of RES and/or EUG to CMC films increased the total phenolic content, free radicals scavenging activity, reducing power, and antibacterial activities of the films (p ≤ .05). Gram-positive bacteria were more susceptible than Gram-negatives. In addition, the combined use of RES and EUG in CMC films had synergistic antioxidant and antagonistic antibacterial effects. The best results belonged to the film containing RES (8 µg/ml) + EUG (8 mg/ml) (p ≤ .05). Considering the results of the present research, we can utilize CMC biodegradable film containing RES and EUG as a natural active packaging in food industry.Entities:
Keywords: antimicrobial; antioxidant; carboxymethyl cellulose; eugenol; resveratrol
Year: 2021 PMID: 35035918 PMCID: PMC8751429 DOI: 10.1002/fsn3.2656
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
FIGURE 1Total phenolic content of CMC films incorporated with RES and EUG (Mean ± SD). Values followed by different letters are significantly different according to Tukey's Multiple Range Test (p ≤ .05)
DPPH scavenging activity of CMC films incorporated with RES or EUG (Mean ± SD)
| Sample | Concentration | Scavenging activity (%) | Sample | Concentration | Scavenging activity (%) |
|---|---|---|---|---|---|
| RES (µg/ml) | 0 | — | EUG (mg/ml) | 0 | — |
| 1 | 61.00 ± 2.65a | 1 | 72.00 ± 2.00a | ||
| 2 | 74.33 ± 2.08b | 2 | 77.33 ± 1.53b | ||
| 4 | 79.33 ± 2.52b | 4 | 82.33 ± 1.53c | ||
| 8 | 87.00 ± 1.00c | 8 | 87.67 ± 1.53d | ||
| BHT (mg/ml) | 1 | 79.00 ± 1.41b | BHT (mg/ml) | 1 | 79.00 ± 1.41bc |
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤ .05).
Reducing power of CMC films incorporated with RES or EUG (Mean ± SD)
| Sample | Concentration | Absorbance at 700 nm | Sample | Concentration | Absorbance at 700 nm |
|---|---|---|---|---|---|
| RES (µg/ml) | 0 | 0.01 ± 0.00a | EUG (mg/ml) | 0 | 0.01 ± 0.00a |
| 1 | 0.21 ± 0.01b | 1 | 0.22 ± 0.00b | ||
| 2 | 0.31 ± 0.01c | 2 | 0.69 ± 0.09c | ||
| 4 | 0.39 ± 0.00d | 4 | 0.91 ± 0.11d | ||
| 8 | 0.59 ± 0.01e | 8 | 1.41 ± 0.05e | ||
| BHT (mg/ml) | 1 | 0.70 ± 0.01f | BHT (mg/ml) | 1 | 0.70 ± 0.01c |
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤ .05).
Antioxidant interactions between RES and EUG in CMC films (Mean ± SD)
| Mixture | DPPH (%) | C.I | Reducing power (Absorbance at 700 nm) | C.I |
|---|---|---|---|---|
| RES (4 µg/ml) + EUG (4 mg/ml) | 88.33 ± 1.15b | 1.09 | 1.28 ± 0.06b | 2.36 |
| RES (8 µg/ml) + EUG (4 mg/ml) | 92.33 ± 0.58c | 1.09 | 1.37 ± 0.00b | 1.9 |
| RES (4 µg/ml) + EUG (8 mg/ml) | 90.33 ± 0.58bc | 1.08 | 1.41 ± 0.01b | 2.33 |
| RES (8 µg/ml) + EUG (8 mg/ml) | 95.33 ± 1.53d | 1.09 | 1.61 ± 0.08c | 1.92 |
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤ .05).
C.I: combination index. (S): Synergistic effect (C.I > 1); (Ad): Additive effect (C.I = 1); (A): Antagonistic effect (C.I < 1).
FIGURE 2Correlation between total phenolic content and antioxidant capacity of CMC films incorporated with RES and EUG based on DPPH (a) and reducing power (b) tests
Antibacterial activity of CMC films incorporated with RES using agar disk diffusion method (Mean ± SD)
| Sample | Concentration | Inhibition zones (mm) | |||
|---|---|---|---|---|---|
|
|
|
|
| ||
| RES (µg/ml) | 1 | 4.67 ± 0.35b (+) | 3.93 ± 0.51b (+) | 3.10 ± 0.53b (+) | 2.57 ± 0.50b (+) |
| 2 | 6.47 ± 0.55c (+) | 5.33 ± 0.50bc (+) | 4.27 ± 0.60bc (+) | 3.77 ± 0.51bc (+) | |
| 4 | 7.73 ± 0.38cd (+) | 7.17 ± 0.64cd (+) | 5.80 ± 0.56cd (+) | 5.43 ± 0.78cd (+) | |
| 8 | 8.87 ± 0.50d (+) | 8.47 ± 0.59d (+) | 7.27 ± 0.55d (+) | 6.87 ± 0.65d (+) | |
| Chl | 30 | 29.03 ± 1.24e (+++) | 28.93 ± 1.30e (+++) | 26.23 ± 0.86e (+++) | 25.57 ± 1.12e (+++) |
(+): Weak antibacterial activity (12 mm ≥ inhibition zone); (++): Moderate antibacterial activity (20 mm > inhibition zone > 12 mm); (+++): Strong antimicrobial activity (20 mm ≤ Inhibition zone).
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤.05).
Chl: Chloramphenicol (positive control).
Antibacterial activity of CMC films incorporated with EUG using agar disk diffusion method (Mean ± SD)
| Sample | Concentration | Inhibition zones (mm) | |||
|---|---|---|---|---|---|
|
|
|
|
| ||
| EUG (mg/ml) | 1 | 7.13 ± 0.83b (+) | 6.63 ± 0.61b (+) | 5.73 ± 0.67b (+) | 5.50 ± 0.40b (+) |
| 2 | 11.90 ± 0.85c (+) | 10.80 ± 1.39c (+) | 10.20 ± 1.21c (+) | 10.17 ± 1.11c (+) | |
| 4 | 15.83 ± 1.04d (++) | 14.67 ± 1.15d (++) | 13.83 ± 1.26d (++) | 13.67 ± 0.42d (++) | |
| 8 | 19.77 ± 0.84e (++) | 18.17 ± 1.26e (++) | 15.83 ± 1.18d (++) | 14.87 ± 1.47d (++) | |
| Chl | 30 | 29.03 ± 1.24f (+++) | 28.93 ± 1.30f (+++) | 26.23 ± 0.86e (+++) | 25.57 ± 1.12e (+++) |
(+): Weak antibacterial activity (12 mm ≥ inhibition zone); (++): Moderate antibacterial activity (20 mm > inhibition zone > 12 mm); (+++): Strong antimicrobial activity (20 mm ≤ Inhibition zone).
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤ .05).
Chl: Chloramphenicol (positive control).
Antibacterial activity of CMC films incorporated with RES using broth dilution method (Mean ± SD)
| Sample | Concentration (µg/ml) |
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B.C | B.R | P.I | B.C | B.R | P.I | B.C | B.R | P.I | B.C | B.R | P.I | ||
| Control | After 0 h | 5.18 ± 0.20a | — | — | 5.23 ± 0.14a | — | — | 5.22 ± 0.09a | — | — | 5.25 ± 0.10a | — | — |
| After 24 h | 6.17 ± 0.07d | — | — | 6.20 ± 0.09d | — | — | 6.20 ± 0.07d | — | — | 6.19 ± 0.12c | — | — | |
| RES | 1 | 5.96 ± 0.08cd | 0.21 (‐) | 3.44 | 6.04 ± 0.14cd | 0.15 (‐) | 2.51 | 6.10 ± 0.15cd | 0.09 (‐) | 1.65 | 6.18 ± 0.09c | 0.01 (‐) | 0.14 |
| 2 | 5.81 ± 0.16c | 0.35 (‐) | 5.81 | 5.86 ± 0.09c | 0.33 (‐) | 5.38 | 5.91 ± 0.09bc | 0.29 (‐) | 4.71 | 5.97 ± .0.11bc | 0.22 (‐) | 3.55 | |
| 4 | 5.67 ± 0.11bc | 0.49 (‐) | 8.09 | 5.73 ± 0.12bc | 0.46 (‐) | 7.49 | 5.80 ± 0.10b | 0.40 (‐) | 6.52 | 5.86 ± 0.07b | 0.34 (‐) | 5.35 | |
| 8 | 5.41 ± 0.06ab | 0.77 (+) | 12.39 | 5.54 ± 0.07ab | 0.66 (+) | 10.67 | 5.70 ± 0.06b | 0.50 (+) | 7.98 | 5.78 ± 0.06b | 0.42 (‐) | 6.59 | |
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤.05).
Bacterial counts [log (CFU/ml)].
Bacterial reduction index. (‐): Nonsignificant antibacterial activity (0.5 > B.R); (+): Slight antibacterial activity (1 > B.R ≥ 0.5); (++): Significant antibacterial activity (3 > B.R ≥ 1); (+++): Strong antibacterial activity (3 ≤ B.R).
Percentage of inhibition (%).
Antibacterial activity of CMC films incorporated with EUG using broth dilution method (Mean ± SD)
| Sample | Concentration (mg/ml) |
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B.C | B.R | P.I | B.C | B.R | P.I | B.C | B.R | P.I | B.C | B.R | P.I | ||
| Control | After 0 h | 5.18 ± 0.20b | — | — | 5.23 ± 0.14b | — | — | 5.22 ± 0.09a | — | — | 5.25 ± 0.10a | — | — |
| After 24 h | 6.17 ± 0.07d | — | — | 6.20 ± 0.09d | — | — | 6.20 ± 0.07d | — | — | 6.19 ± 0.12c | — | — | |
| EUG | 1 | 5.82 ± 0.19cd | 0.33 (‐) | 5.76 | 5.91 ± 0.10cd | 0.28 (‐) | 4.58 | 6.03 ± 0.12cd | 0.16 (‐) | 2.73 | 6.15 ± 0.10c | 0.04 (‐) | 0.65 |
| 2 | 5.52 ± 0.15bc | 0.64 (+) | 10.58 | 5.64 ± 0.15c | 0.55 (+) | 9.01 | 5.85 ± 0.13bc | 0.34 (‐) | 5.66 | 5.97 ± 0.08bc | 0.23 (‐) | 3.66 | |
| 4 | 5.18 ± 0.12b | 0.99 (+) | 16.14 | 5.31 ± 0.08b | 0.89 (+) | 14.28 | 5.68 ± 0.04b | 0.52 (+) | 8.34 | 5.79 ± 0.09b | 0.41 (‐) | 6.50 | |
| 8 | 4.68 ± 0.08a | 1.49 (++) | 24.09 | 4.82 ± 0.09a | 1.38 (++) | 22.19 | 5.24 ± 0.13a | 0.95 (+) | 15.45 | 5.33 ± 0.10a | 0.87 (+) | 13.94 | |
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤.05).
Bacterial counts [log (CFU/ml)]
Bacterial reduction index. (‐): Nonsignificant antibacterial activity (0.5 > B.R); (+): Slight antibacterial activity (1 > B.R ≥ 0.5); (++): Significant antibacterial activity (3 > B.R ≥ 1); (+++): Strong antibacterial activity (3 ≤ B.R).
Percentage of inhibition (%).
Antibacterial interactions between RES and EUG in CMC films using agar disk diffusion method (Mean ± SD)
| Bacteria | Inhibition Zones (mm) | |||||||
|---|---|---|---|---|---|---|---|---|
| Expected inhibition zones | Occurred inhibition zones | |||||||
| RES (4 µg/ml) + EUG (4 mg/ml) | RES (8 µg/ml) + EUG (4 mg/ml) | RES (4 µg/ml) + EUG (8 mg/ml) | RES (8 µg/ml) + EUG (8 mg/ml) | RES (4 µg/ml) + EUG (4 mg/ml) | RES (8 µg/ml) + EUG (4 mg/ml) | RES (4 µg/ml) + EUG (8 mg/ml) | RES (8 µg/ml) + EUG (8 mg/ml) | |
|
| 23.56 | 24.70 | 27.50 | 28.33 | 18.73 ± 0.46a (A) (++) | 19.07 ± 0.42a (A) (++) | 21.53 ± 0.35b (A) (+++) | 22.10 ± 0.40b (A)(+++) |
|
| 21.83 | 23.13 | 25.33 | 26.63 | 18.17 ± 0.45a (A) (++) | 18.77 ± 0.60a (A) (++) | 20.53 ± 0.42b (A) (+++) | 21.47 ± 0.42b (A) (+++) |
|
| 19.63 | 21.10 | 21.63 | 23.10 | 16.07 ± 0.42a (A) (++) | 16.40 ± 0.66a (A) (++) | 17.63 ± 0.35b (A) (++) | 18.73 ± 0.32b (A) (++) |
|
| 19.10 | 20.53 | 20.30 | 21.73 | 15.37 ± 0.51a (A) (++) | 16.07 ± 0.42a (A) (++) | 17.40 ± 0.26b (A) (++) | 18.07 ± 0.32b (A) (++) |
(S): Synergistic effect; (Ad): Additive effect; (A): Antagonistic effect.
(+): Weak antibacterial activity (12 mm ≥ inhibition zone); (++): Moderate antibacterial activity (20 mm > inhibition zone > 12 mm); (+++): Strong antimicrobial activity (20 mm ≤ Inhibition zone).
Values followed by different letters within the same rows are significantly different according to the Tukey's test (p ≤ .05).
Antibacterial interactions between RES and EUG in CMC films using broth dilution method (Mean ± SD)
| Sample |
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B.C | B.R | P.I | B.C | B.R | P.I | B.C | B.R | P.I | B.C | B.R | P.I | |
| Control (after 0 h) | 5.18 ± 0.20c | — | — | 5.23 ± 0.14b | — | — | 5.22 ± 0.09bc | — | — | 5.25 ± 0.10bc | — | — |
| Control (after 24 h) | 6.17 ± 0.07d | — | — | 6.20 ± 0.09c | — | — | 6.20 ± 0.07e | — | — | 6.19 ± 0.12e | — | — |
| RES (4 µg/ml) + EUG (4 mg/ml) | 5.03 ± 0.08bc | 1.14 (++) | 18.53 | 5.13 ± 0.06b | 1.07 (++) | 17.20 | 5.51 ± 0.04d | 0.69 (+) | 11.15 | 5.62 ± 0.07d | 0.58 (+) | 9.31 |
| RES (8 µg/ml) + EUG (4 mg/ml) | 4.81 ± 0.08b | 1.36 (++) | 22.03 | 5.03 ± 0.04b | 1.17 (++) | 18.87 | 5.35 ± 0.05cd | 0.85 (+) | 13.76 | 5.43 ± 0.09cd | 0.76 (+) | 12.27 |
| RES (4 µg/ml) + EUG (8 mg/ml) | 4.51 ± 0.05a | 1.66 (++) | 26.89 | 4.64 ± 0.10a | 1.55 (++) | 25.05 | 5.06 ± 0.08b | 1.14 (++) | 18.40 | 5.11 ± 0.07ab | 1.09 (++) | 17.46 |
| RES (8 µg/ml) + EUG (8 mg/ml) | 4.36 ± 0.07a | 1.82 (++) | 29.043 | 4.52 ± 0.03a | 1.69 (++) | 27.11 | 4.84 ± 0.10a | 1.36 (++) | 22.00 | 4.95 ± 0.03a | 1.25 (++) | 20.09 |
Values followed by different letters within the same columns are significantly different according to the Tukey's test (p ≤ .05).
Bacterial counts [log (CFU/ml)].
Bacterial reduction index. (‐): Nonsignificant antibacterial activity (0.5 > B.R); (+): Slight antibacterial activity (1 > B.R ≥ 0.5); (++): Significant antibacterial activity (3 > B.R ≥ 1); (+++): Strong antibacterial activity (3 ≤ B.R).
Percentage of bacterial growth inhibition (%).